This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 April 2023 and includes updates on influenza, Marburg virus disease, COVID-19, MERS-CoV, Measles and diphtheria.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing again to 15% positivity for week 14/2023.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 April 2023 and includes updates on mpox, Group A streptococcal, Influenza A(H5N1) infection, and Marburg virus disease.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 March - 1 April 2023 and includes updates on Iatrogenic botulism exposure in Türkiye, COVID-19, group A streptococcal infection, influenza, swine influenza. Marburg virus disease and poliomyelitis.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023 when it reached 22% positivity before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 before decreasing again to 22% positivity in week 12/2023.
Since June 2017, a persistent cross-border outbreak of Salmonella Virchow ST16 has been ongoing in five EU/EEA countries, the UK, and the US, according to a Rapid Outbreak Assessment released by ECDC and EFSA today.
Since June 2017, a cross-border outbreak of Salmonella Virchow ST16 has been ongoing in five EU/EEA countries, the UK, and the US. A total of 210 cases have been reported. No deaths have been reported. A majority of cases have been linked to local restaurants serving kebab meat.
The December 2022 characterisation report, was the third report for the 2022-2023 influenza season. Currently, as of week 08/2023, 231 015 detections have been reported.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism, COVID-19, Influenza, Group A streptococcal infection, cholera, poliomyelitis, measles, and extensively drug-resistant Pseudomonas aeruginosa.